Document is current
Any future updates will be listed below
-
Authors
Rosas, José
Belzunegui, Joaquín
Hernández-Cruz, Blanca
Aguirregabiria, Itxaso https://orcid.org/0000-0002-1889-3957
Moyano, Sebastián
Cobo, Amelia
Díaz-Cerezo, Silvia
-
Funding
Funding for this research was provided by:
The preparation of the manuscript and the journals’ Rapid Service and Open Access fees, were funded by Eli Lilly and Company.
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 27 February 2025
First Online: 22 March 2025
Declarations
:
: José Rosas reports consultant fees and/or honoraria and/or travel support from: AbbVie, AstraZeneca, Galapagos, GSK, Lilly, Novartis and UCB. Joaquín Belzunegui and Blanca Hernandez-Cruz have no conflicts to declare. Itxaso Aguirregabiria, Sebastián Moyano, Amelia Cobo and Silvia Díaz-Cerezo, are employees and minor shareholders of Eli Lilly and Company.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
